{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:28Z","timestamp":1791312808027,"version":"4.3.1"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Primary aldosteronism (PA) is the most common cause of secondary hypertension. Surgery is the mainstay of treatment for unilateral dominant PA, but reported cure rates varies. The aim of the present study was to investigate contemporary follow\u2010up practices and cure rates after surgery for PA in Sweden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients operated for PA and registered in the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery (SQRTPA) 2009\u20132015 were identified. Patient data were extracted, and follow\u2010up data (1\u201324\u00a0months) was recorded. Doses of antihypertensive medication and potassium supplementation were calculated using defined daily doses (DDD), and the Primary Aldosteronism Surgical Outcome (PASO) criteria were used to evaluate outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 190 registered patients, 171 (47% female, mean age 53 years, median follow\u2010up 3.7\u00a0months) were available for analysis. In 75 patients (44%), missing data precluded evaluation of biochemical cure according to the PASO criteria. Minimal invasive approach was used in 168\/171 patients (98%). Complication rate (Clavien\u2010Dindo &gt;3a) was 3%. No mortality was registered. Pre\/postoperatively 98\/66% used antihypertensives (mean DDD 3.7\/1.5). 89\/2% had potassium supplementation (mean DDD 2.0\/0) before\/after surgery. Complete\/partial biochemical and clinical success according to the PASO criteria were achieved in 92\/7% and 34\/60%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this study, reflecting contemporary clinical practice in Sweden complete\/partial biochemical and clinical success after surgery for PA was 92\/7% and 34\/60%. Evaluation of biochemical cure was hampered by lack of uniform reporting of relevant outcome measures. We suggest mandatory reporting of surgical outcomes using the PASO criteria for all units performing surgery for PA.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00268-019-05265-8","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T16:13:31Z","timestamp":1576512811000},"page":"561-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden"],"prefix":"10.1002","volume":"44","author":[{"given":"Fredrik","family":"Sellgren","sequence":"first","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"},{"name":"Department of Surgery Sahlgrenska University Hospital Bla straket 5 41345 Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koman","sequence":"additional","affiliation":[{"name":"Department of Endocrine Tumours and Sarcoma Karolinska University Hospital Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Sarcoma Surgery Sk\u00e5ne University Hospital Lund Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellman","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences Uppsala University Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Hennings","sequence":"additional","affiliation":[{"name":"Department of Surgical and Perioperative Sciences Ume\u00e5 University Ume\u00e5 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Muth","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn JW","year":"1955","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_3_1","unstructured":"FunderJW CareyRM FardellaCet al. Case detection diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.J Clin Endocrinol Metab(2008)10.1210\/jc.2008\u2010010418552288"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100031\u20101295438"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102265.2007.02775.x"},{"key":"e_1_2_7_6_1","unstructured":"DoumaS PetidisK DoumasMet al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.Lancet(2008)10.1016\/S0140\u20106736(08)60834\u2010X18805319"},{"key":"e_1_2_7_7_1","unstructured":"Born\u2010FrontsbergE ReinckeM RumpLCet al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German conn\u2019s registry.J Clin Endocrinol Metab(2009)10.1210\/jc.2008\u2010211619190103"},{"key":"e_1_2_7_8_1","doi-asserted-by":"crossref","unstructured":"SavardS AmarL PlouinPF SteichenOCardiovascular complications associated with primary aldosteronism: a controlled cross\u2010sectional study.Hypertension(2013)10.1161\/HYPERTENSIONAHA.113.0106023753408","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","unstructured":"MilliezP GirerdX PlouinPFet al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.J Am Coll Cardiol(2005)10.1016\/j.jacc.2005.01.01515837256","DOI":"10.1016\/j.accreview.2005.08.031"},{"key":"e_1_2_7_10_1","unstructured":"MulateroP MonticoneS BertelloCet al. Long\u2010term cardio\u2010 and cerebrovascular events in patients with primary aldosteronism.J Clin Endocrinol Metab(2013)10.1210\/jc.2013\u20102805240572883816265"},{"key":"e_1_2_7_11_1","unstructured":"RossiGP BerniniG DesideriGet al. Renal damage in primary aldosteronism: results of the PAPY study.Hypertension(2006)10.1161\/01.HYP.0000230444.01215.6a16801482"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2013.785234"},{"key":"e_1_2_7_13_1","unstructured":"FunderJW CareyRM ManteroFet al. The management of primary aldosteronism: case detection diagnosis and treatment: an endocrine society clinical practice guideline.J Clin Endocrinol Metab(2016)10.1210\/jc.2015\u2010406126934393"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE\u201017\u20100990"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9744"},{"key":"e_1_2_7_16_1","doi-asserted-by":"crossref","unstructured":"ProyeCAG MulliezEAR CarnailleBMLet al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?.Surgery(1998)10.1067\/msy.1998.931089854595","DOI":"10.1067\/msy.1998.93108"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","unstructured":"SechiLA NovelloM LapennaRet al. Long\u2010term renal outcomes in patients with primary aldosteronism.J Am Med Assoc(2006)10.1001\/jama.295.22.2638","DOI":"10.1001\/jama.295.22.2638"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100031\u20101299681"},{"key":"e_1_2_7_19_1","unstructured":"RossiGP BolognesiM RizzoniDet al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.Hypertension(2008)10.1161\/HYPERTENSIONAHA.108.11136918852391"},{"key":"e_1_2_7_20_1","unstructured":"VorselaarsWMCM NellS PostmaELet al. Clinical outcomes after unilateral adrenalectomy for primary aldosteronism.JAMA Surg(2019)10.1001\/jamasurg.2018.5842308107496484800"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30135\u20103"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434\u2010011\u20102121\u20105"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.141.5.497"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011\u20102830"},{"key":"e_1_2_7_25_1","article-title":"[The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors]","volume":"112","author":"Ragnarsson O","year":"2015","journal-title":"Lakartidningen"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328364ca4c"},{"key":"e_1_2_7_27_1","unstructured":"Vander SticheleRH ElseviersMM FerechMet al. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.Br J Clin Pharmacol(2004)10.1111\/j.1365\u20102125.2004.02164.x153739351884596"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268\u2010017\u20104311\u20101"},{"key":"e_1_2_7_30_1","unstructured":"PasquierL KirouaniM FangetFet al. Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients.Langenbeck\u2019s Arch Surg(2017)10.1007\/s00423\u2010017\u20101557\u2010x"},{"key":"e_1_2_7_31_1","unstructured":"ZarnegarR YoungWF LeeJet al. The aldosteronoma resolution score.Ann Surg(2008)10.1097\/sla.0b013e318165c07518376197"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","unstructured":"MulateroP StowasserM LohKCet al. Increased diagnosis of primary aldosteronism including surgically correctable forms in centers from five continents.J Clin Endocrinol Metab(2004)10.1210\/jc.2003\u201003133715240589","DOI":"10.1097\/00004872-200406002-00629"},{"key":"e_1_2_7_33_1","volume-title":"Moderately elevated blood pressure: a systematic review","author":"Assessment SC on HT","year":"2004"},{"key":"e_1_2_7_34_1","doi-asserted-by":"crossref","unstructured":"SigurjonsdottirHA GronowitzM AnderssonOet al. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study.BMC Endocr Disord(2012)10.1186\/1472\u20106823\u201012\u201017229586743515501","DOI":"10.1186\/1472-6823-12-17"},{"key":"e_1_2_7_35_1","doi-asserted-by":"crossref","unstructured":"WesterdahlC BergenfelzA IsakssonAet al. High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.Scand J Prim Health Care(2006)10.1080\/0281343060083093116923624","DOI":"10.1080\/02813430600830931"},{"key":"e_1_2_7_36_1","unstructured":"WesterdahlC BergenfelzA IsakssonAet al. Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area.Scand J Prim Health Care(2011)10.3109\/02813432.2011.554015213234983347934"},{"key":"e_1_2_7_37_1","unstructured":"JakobssonH FarmakiK SakinisAet al. Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.Diagnostic Interv Radiol(2018)10.5152\/dir.2018.17397"},{"key":"e_1_2_7_38_1","doi-asserted-by":"crossref","unstructured":"HarveyA PasiekaJL KlineG SoBModification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism.Surgery (United States)(2012)10.1016\/j.surg.2012.07.007","DOI":"10.1016\/j.surg.2012.07.007"},{"key":"e_1_2_7_39_1","doi-asserted-by":"crossref","unstructured":"KlineGA ChinA SoBet al. Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome.Clin Endocrinol (Oxf)(2015)10.1111\/cen.12669","DOI":"10.1530\/endoabs.34.P341"},{"key":"e_1_2_7_40_1","unstructured":"VolpeC HambergerB H\u00f6\u00f6gAet al. Primary aldosteronism: functional histopathology and long\u2010term follow\u2010up after unilateral adrenalectomy.Clin Endocrinol (Oxf)(2015)10.1111\/cen.12645"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-019-05265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00268-019-05265-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-019-05265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s00268-019-05265-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T16:08:43Z","timestamp":1704643723000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s00268-019-05265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1007\/s00268-019-05265-8"],"URL":"https:\/\/doi.org\/10.1007\/s00268-019-05265-8","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"11 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interests or disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}